Attorney Jessica Paluch-Hoerman, founder of TruLaw, has over 28 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.
TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.
Question: Do you qualify to file a Sterigenics Willowbrook Lawsuit?
Answer: Residents exposed to hazardous emissions from the now-shuttered Willowbrook Sterigenics facility may still have viable claims despite the $408 million settlement that resolved 879 ethylene oxide cases in January 2023.
On this page, we’ll discuss this question in further depth, Sterigenics Willowbrook vs Other EtO Lawsuits, and much more.
The Environmental Protection Agency classified ethylene oxide as a known human carcinogen, and those who developed cancer after living or working near the commercial sterilization facilities at 7775 Quincy Street in Willowbrook may qualify to seek financial compensation through ongoing litigation against Sterigenics and its parent company, Sotera Health.
The EPA’s risk assessment estimated that local residents living near the facility faced lifetime cancer risks as high as 1,000 in 1 million, exceeding the agency’s acceptable risk threshold of 100 in 1 million.
If you or a loved one lived, worked, or attended school near the Sterigenics Willowbrook facility and were later diagnosed with serious illness, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to determine your eligibility to file an Ethylene Oxide Lawsuit today.
Establishing a strong claim for toxic exposure from the Willowbrook facility requires comprehensive documentation of your residential proximity to 7775 Quincy Street and medical records confirming a cancer diagnosis linked to ETO exposure.
The Environmental Protection Agency’s air monitoring data from 2018 revealed that the Willowbrook Sterigenics facility posed increased cancer risks to surrounding communities, with cancer rates exceeding acceptable thresholds by up to ten times the national average.
Documentation needed to support your claim involves:
Your attorney will use EPA monitoring data and expert testimony to establish that hazardous emissions from Willowbrook operations created an elevated cancer risk for those in the surrounding area.
The stronger your documentation of both exposure duration and medical diagnosis, the more compelling your case becomes.
Victims who developed cancer or other serious health effects from ethylene oxide exposure may recover substantial compensation for both economic and non-economic damages through litigation against Sterigenics.
A Cook County jury awarded Sue Kamuda $363 million in September 2022, including $38 million in compensatory damages and $325 million in punitive damages, demonstrating the potential value of these claims for those harmed by the company’s hazardous emissions.
Recoverable damages in ethylene oxide cases encompass both immediate and long-term impacts, including past and future medical expenses for cancer treatment, lost wages and diminished earning capacity, and compensation for pain and suffering endured during treatment and recovery.
Courts also recognize emotional distress and mental anguish, loss of enjoyment of life and normal activities, and in cases of willful corporate misconduct, substantial punitive damages designed to punish and deter such behavior.
For families who lost loved ones to cancer, wrongful death damages provide compensation for both economic losses and the immeasurable loss of companionship.
The $363 million jury verdict awarded to Susan Kamuda represents one specific case outcome and is not indicative of typical results.
Each case is unique, and outcomes depend on individual facts and circumstances.
If you or a loved one lived near the Willowbrook Sterigenics facility and developed cancer after exposure to ethylene oxide emissions, you may be entitled to compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to file an Ethylene Oxide Lawsuit today.
In January 2023, Sterigenics and parent company Sotera Health agreed to pay $408 million to resolve 879 pending ethylene oxide cases connected to the now-closed Willowbrook facility, marking one of the largest environmental toxic exposure settlements in Illinois history.
This massive settlement came just months after a Cook County Circuit Court jury awarded Susan Kamuda $363 million in damages, sending a clear message that juries were prepared to hold the company accountable for decades of hazardous emissions that exposed communities to a known carcinogen.
The $408 million settlement represents one of the largest mass tort resolutions for environmental toxic exposure in recent years.
This settlement surpassed many other environmental exposure cases nationwide, reflecting both the severity of health impacts and the strength of evidence showing that the Willowbrook Sterigenics facility operated without adequate emission controls while the Environmental Protection Agency and state regulators documented cancer risks far exceeding acceptable levels.
The settlement structure included provisions for individual claim evaluations based on cancer type and severity, with compensation tiers reflecting different levels of exposure and harm.
The agreement established expedited payment processes to provide relief to cancer survivors while ensuring legal fee arrangements allowed eligible claimants to receive maximum compensation.
Three claimants exercised opt-out provisions to pursue individual trials, believing they could achieve outcomes similar to the Kamuda verdict.
The settlement administration process required substantially all plaintiffs to provide opt-in consents, with 99.7% participation achieved by June 2023.
This overwhelming acceptance rate demonstrated the settlement’s fairness and the plaintiffs’ desire to secure compensation without enduring lengthy trials while battling cancer and other serious health effects from their toxic exposure.
In September 2022, a Cook County jury delivered a stunning verdict awarding breast cancer survivor Susan Kamuda $363 million in damages against Sterigenics, including $38 million in compensatory damages and $325 million in punitive damages designed to punish the company for its conduct.
The jury found that Sterigenics knew its Willowbrook operations exposed nearby residents to dangerous levels of ethylene oxide but failed to implement available emission controls, with evidence showing the company explicitly told regulators it “does not want to control its emissions” as early as 1985.
During the five-week trial, jurors heard compelling evidence including EPA monitoring emissions data showing cancer risks up to 10 times acceptable levels and internal company documents acknowledging emission concerns.
Expert testimony established clear links between ethylene oxide and breast cancer, while Kamuda’s medical records showed no family history of cancer despite her 30+ years living just one-third mile from the facility.
Community health studies documented elevated cancer rates in the area, painting a damning picture of corporate negligence.
Please be advised that all settlement ranges mentioned on this page are historical examples from past settlements and are not guaranteed for future cases.
These figures represent specific outcomes from the past settlement and should not be taken as definitive expectations for your case.
Individual compensation depends on numerous factors including diagnosis severity, exposure duration, medical costs, and case-specific evidence.
If you were diagnosed with breast cancer, lymphoma, or leukemia after living within 5 miles of the Sterigenics Willowbrook plant, you may still have a viable claim for compensation.
Contact TruLaw using the chat on this page for a free consultation to see if you’re eligible to join others filing a Sterigenics lawsuit today.
The Willowbrook Sterigenics facility permanently ceased operations in 2019 following unprecedented state intervention triggered by alarming air monitoring results that revealed the highest levels of ethylene oxide ever recorded in the area.
Illinois EPA Acting Director John Kim issued an emergency seal order on February 15, 2019, immediately halting all sterilization cycles after the company refused to voluntarily suspend operations despite mounting evidence of public health risks and intense community pressure from residents who had organized “Stop Sterigenics” campaigns.
The path to closure began in late 2018 when Environmental Protection Agency monitoring detected cancer-causing ethylene oxide concentrations that posed what officials called “an imminent and substantial endangerment” to nearby residents and workers.
Independent 30-day air monitoring tests conducted in early 2019 not only showed extreme daily fluctuations in ethylene oxide levels but recorded the highest concentrations ever measured near the facility, prompting Willowbrook Mayor Frank Trilla to declare that “these new test results prove one thing; Sterigenics needs to be shut down.”
Timeline of key events leading to permanent closure consists of:
Despite Sterigenics’ attempts to reopen with enhanced emission controls following the seal order, sustained community opposition, political pressure from Governor J.B. Pritzker, and the prospect of continued litigation made resuming operations untenable.
The permanent closure on September 30, 2019, marked a victory for public health advocates and residents who had fought for years to address the safety risk posed by the commercial sterilization facilities, though many continued to seek financial compensation for cancers they developed during decades of exposure to hazardous emissions.
If you or someone you know developed cancer or other serious health conditions from ethylene oxide exposure at the Willowbrook facility, financial compensation may be available.
Contact TruLaw using the chat on this page to receive an instant case evaluation and learn about filing an EtO Lawsuit today.
The mass tort litigation against Sterigenics stems from decades of operations at the Willowbrook facility, where the company used ethylene oxide to sterilize medical devices and equipment without adequately controlling emissions that exposed surrounding communities to a known carcinogen.
The Environmental Protection Agency has classified ethylene oxide as a hazardous air pollutant under the Clean Air Act, and both the EPA and International Agency for Research on Cancer recognize it as a Group 1 human carcinogen with sufficient evidence linking exposure to various cancers in humans, particularly breast cancer and cancers of the white blood cells.
The Willowbrook Sterigenics facility operated at two locations from 1984 until 2019, using massive quantities of ethylene oxide as a sterilizing agent to disinfect medical equipment while releasing thousands of pounds of the toxic gas into surrounding neighborhoods annually.
According to Illinois Department of Public Health records, the sterilization plant released between 17,000 and 33,000 pounds of ethylene oxide each year before 1999, with emissions continuing at approximately 5,000 pounds annually thereafter until enhanced controls were implemented following public outcry and regulatory pressure in 2018.
The Environmental Protection Agency’s 2014 National Air Toxics Assessment identified the area surrounding the Willowbrook facility as having elevated cancer risks, with subsequent monitoring in 2018 confirming that ethylene oxide concentrations posed what regulators called an “imminent and substantial endangerment” to public health.
Evidence presented during pretrial discovery in litigation revealed that Sterigenics explicitly told regulators it “does not want to control its emissions” as early as 1985, demonstrating decades of corporate indifference to community safety while the company profited from sterilizing medical devices using methods that put thousands at risk of developing cancer.
The Willowbrook litigation represents the largest and most successful ethylene oxide exposure case to date, with the $408 million settlement far exceeding recoveries in other states and setting important precedents for holding commercial sterilization facilities accountable for community health impacts.
While similar lawsuits have emerged across the country targeting facilities that use ethylene oxide to sterilize medical equipment, the combination of strong scientific evidence, organized community advocacy, and favorable Illinois law created uniquely powerful conditions that led to the record-breaking settlement for those exposed to hazardous emissions.
The stark contrast between Willowbrook’s $408 million settlement for 879 claimants and Georgia’s $35 million settlement for just 79 claims demonstrates how location, regulatory environment, and jury composition impact case outcomes.
The Georgia litigation, targeting Sterigenics’ Cobb County facility near Atlanta, resolved in October 2023 for less than one-tenth the total value despite similar allegations that the sterilization plant exposed nearby residents to cancer-causing emissions, with approximately 400 additional claims still pending that may increase the ultimate settlement value.
Comparison of major EtO litigation settlements demonstrates the following patterns:
Unlike Willowbrook, which permanently closed in 2019 following state intervention, many facilities involved in litigation continue operating while implementing enhanced emission controls to reduce emissions.
The Atlanta-area Sterigenics facility remains operational despite ongoing lawsuits, as does B. Braun Medical’s Pennsylvania plant, creating continued exposure risks for nearby communities while legal battles proceed over past damages from decades of toxic exposure.
Settlement values in ethylene oxide cases vary dramatically based on state tort laws, caps on damages, jury attitudes toward corporate defendants, and the strength of environmental regulations in each jurisdiction.
Illinois courts have proven particularly favorable to plaintiffs, with no caps on punitive damages and juries willing to hold companies accountable for prioritizing profits over public safety, as demonstrated by the $325 million punitive damage award in the Kamuda case that prompted the global settlement.
Several factors influence settlement values across states, including damage caps and tort reform limitations that restrict recovery in some jurisdictions, along with varying state environmental regulations and enforcement histories.
The number of plaintiffs and ability to consolidate cases affects leverage in negotiations, while the political climate regarding environmental protection can influence both regulatory action and jury sympathy.
The average settlement amount represents a mathematical calculation from one specific group settlement and does not predict individual case values.
Actual compensation varied significantly above and below this average based on individual circumstances.
Future cases may result in different outcomes due to changing legal standards, available evidence, and case-specific factors.
No attorney can guarantee any specific settlement amount.
If you lived, worked, or attended school near the Sterigenics facility at 7775 Quincy Street and later developed cancer, you may qualify for substantial compensation.
Contact TruLaw using the chat on this page for a free case review to determine your eligibility for a Willowbrook Lawsuit today.
The Environmental Protection Agency has determined that chronic exposure to ethylene oxide from commercial sterilization facilities poses severe health risks, with scientific evidence demonstrating clear links between long-term inhalation and multiple types of cancer.
EPA risk assessments specific to the Willowbrook Sterigenics facility found that residents faced lifetime cancer risks up to 1,000 per million people—far exceeding the agency’s acceptable risk threshold of 100 per million—with risks increasing based on proximity to the sterilization plant and duration of exposure to hazardous emissions.
The Environmental Protection Agency has identified ethylene oxide as a potent human carcinogen that causes multiple cancer types, with particularly strong evidence linking exposure to breast cancer in women and various cancers of the white blood cells.
Studies of workers in sterilization facilities and residents living near plants that sterilize medical devices have consistently shown elevated rates of these cancers, leading regulatory agencies worldwide to classify ethylene oxide in the highest risk category for cancer-causing substances.
Cancers associated with ethylene oxide exposure feature research such as:
The biological mechanism by which ethylene oxide causes cancer involves its ability to damage DNA directly, creating mutations that can lead to uncontrolled cell growth.
This highly reactive alkylating agent forms DNA adducts that interfere with normal cellular function, and because it readily penetrates tissues and crosses biological barriers, exposure through inhalation can affect multiple organ systems throughout the body.
EPA scientists have found particularly strong associations between ethylene oxide exposure and cancers affecting the blood-forming system, with studies showing workers and residents exposed to emissions from facilities that sterilize medical equipment face elevated risks of developing these often-fatal diseases.
The agency’s comprehensive risk assessment determined that ethylene oxide causes non-Hodgkin lymphoma, multiple myeloma, and lymphocytic leukemia at rates far exceeding background levels in unexposed populations, with risks increasing substantially for those living closest to emission sources.
The evidence supporting links to blood cancers is compelling and multifaceted.
Studies in occupational settings consistently show 2-3 times higher rates in exposed workers, while community health surveys have documented cancer clusters near facilities.
The biological plausibility is well-established based on ethylene oxide’s mutagenic properties, with clear dose-response relationships demonstrating that higher exposure equals greater risk.
This consistency across multiple epidemiological studies worldwide, combined with confirming animal studies showing carcinogenic effects on blood cells, provides overwhelming scientific support for causation.
The latency period for these cancers can range from several years to decades after initial exposure, meaning residents who lived near the Willowbrook facility during its 35 years of operation may still develop cancer years after the plant’s closure.
Children exposed to ethylene oxide face particularly high risks due to their developing immune systems and longer remaining lifespans during which cancers may emerge.
Beyond its established role as a carcinogen, ethylene oxide exposure causes numerous non-cancer health effects that can impact quality of life and require ongoing medical treatment.
Acute exposure to higher concentrations causes immediate respiratory irritation, while chronic lower-level exposure—such as that experienced by local communities near sterilization facilities—can lead to persistent neurological symptoms including impaired coordination, reproductive problems, and damage to multiple organ systems that may not manifest until years after initial exposure.
Non-cancer health effects documented in exposed populations involve methods such as:
Scientific studies have shown that even exposure levels previously considered “safe” can cause measurable biological changes, including DNA damage and oxidative stress markers.
If you or a family member were exposed to toxic emissions from the Willowbrook Sterigenics plant between 1984-2019 and developed cancer, you may be eligible to seek damages.
Contact TruLaw using the chat on this page to receive an instant case evaluation and explore your options for filing an Ethylene Oxide Exposure Lawsuit today.
Our Ethylene Oxide Exposure attorney at TruLaw is dedicated to supporting clients through the process of filing an Ethylene Oxide Exposure lawsuit.
With extensive experience in toxic chemical exposure cases, Jessica Paluch-Hoerman and our partner law firms work with litigation leaders and medical experts to prove how ethylene oxide emissions from industrial facilities caused you harm.
TruLaw focuses on securing compensation for medical expenses, cancer treatments, pain and suffering, lost income, and other damages resulting from your ethylene oxide exposure injuries.
We recognize that cancer often develops in specific areas near industrial facilities, sometimes referred to as cancer alleys, where multiple sources of toxic emissions including ethylene oxide and other chemicals combine to create heightened health risks for residents.
Meet our lead Ethylene Oxide Exposure attorney:
At TruLaw, we believe financial concerns should never stand in the way of justice.
That’s why we operate on a contingency fee basis—with this approach, you only pay legal fees after you’ve been awarded compensation for your injuries.
If you or a loved one developed cancer or other health problems after being exposed to ethylene oxide emissions from nearby industrial facilities, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine whether you qualify to join others in filing an Ethylene Oxide Exposure lawsuit today.
Ethylene oxide exposure lawsuits are being filed by individuals across the country who developed cancer and other serious health conditions after being exposed to industrial emissions of this toxic gas.
TruLaw is currently accepting clients for the ethylene oxide exposure lawsuit.
A few reasons to choose TruLaw for your ethylene oxide exposure lawsuit include:
If you or a loved one developed breast cancer, lymphoma, leukemia, or other health problems after being exposed to ethylene oxide emissions from nearby industrial facilities, you may be eligible to seek compensation.
Contact TruLaw using the chat on this page to receive an instant case evaluation that can determine if you qualify for the Ethylene Oxide Lawsuit today.
The $408 million settlement reached in January 2023 provided an average of approximately $464,000 per claimant among the 879 participants, though individual amounts varied based on factors including cancer type, age at diagnosis, medical expenses, and severity of health impacts.
Some victims with aggressive cancers or extensive treatment costs received substantially more than the average, while the three plaintiffs who opted out of the settlement pursued individual trials that could result in verdicts similar to Susan Kamuda’s $363 million award.
These historical figures are provided for informational purposes only and should not be interpreted as a guarantee or prediction of compensation for any future claim.
Each case is evaluated individually, and compensation depends on multiple factors that vary by claimant. Many cases result in no recovery.
Contact TruLaw using the chat on this page to discuss your potential eligibility and case value.
New claims may still be viable for individuals who were not part of the original 879-person settlement group, particularly those who have recently been diagnosed with cancer or were unaware of their eligibility during the settlement period.
The discovery rule in Illinois toxic exposure cases may extend filing deadlines for those who only recently learned about the connection between their cancer and ethylene oxide emissions from the Willowbrook facility, making it important to consult with an attorney promptly to determine whether you can still pursue compensation.
The Sterigenics plant permanently closed on September 30, 2019, following an emergency seal order issued by the Illinois EPA on February 15, 2019, that immediately halted operations due to “imminent and substantial endangerment” to public health.
The closure came after EPA monitoring revealed the highest ethylene oxide levels ever recorded in the area, intense community pressure from organized “Stop Sterigenics” campaigns, and political intervention from Governor Pritzker, making it impossible for the company to resume operations despite attempts to implement enhanced emission controls.
Yes, the Environmental Protection Agency has classified ethylene oxide as a known human carcinogen based on extensive scientific evidence showing it causes multiple types of cancer, including breast cancer, non-Hodgkin lymphoma, multiple myeloma, and various forms of leukemia.
Studies of both workers in sterilization facilities and residents living near plants have consistently demonstrated elevated cancer rates, with the EPA determining that long-term exposure creates unacceptable health risks even at relatively low concentrations in ambient air.
No, Sterigenics maintains it never admitted liability for cancer cases linked to its Willowbrook facility, with the $408 million settlement explicitly stating it should not be construed as an admission of wrongdoing or that emissions posed any safety hazard to surrounding communities.
Despite maintaining this legal position, the company agreed to the massive settlement following the $363 million Kamuda verdict, recognizing the financial risks of continued litigation as hundreds of cancer victims prepared to present evidence of decades of harmful emissions and corporate knowledge of health risks.
Ethylene oxide remains widely used in commercial sterilization facilities because it effectively kills bacteria, viruses, and fungi on heat-sensitive medical devices that cannot withstand steam sterilization, penetrating packaging and device geometries while maintaining material integrity.
Despite its effectiveness at sterilizing approximately 50% of medical devices in the United States, safer alternatives exist for many applications, and the severe health risks associated with community exposure have led to increased pressure on the industry to transition to less hazardous sterilization methods.
Managing Attorney & Owner
With over 25 years of legal experience, Jessica Paluch-Hoerman is an Illinois lawyer, a CPA, and a mother of three. She spent the first decade of her career working as an international tax attorney at Deloitte.
In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.
In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share the most reliable, accurate, and up-to-date legal information with our readers!
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TruLaw, we fiercely combat corporations that endanger individuals’ well-being. If you’ve suffered injuries and believe these well-funded entities should be held accountable, we’re here for you.
With TruLaw, you gain access to successful and seasoned lawyers who maximize your chances of success. Our lawyers invest in you—they do not receive a dime until your lawsuit reaches a successful resolution!
AFFF Lawsuit claims are being filed against manufacturers of aqueous film-forming foam (AFFF), commonly used in firefighting.
Claims allege that companies such as 3M, DuPont, and Tyco Fire Products failed to adequately warn users about the potential dangers of AFFF exposure — including increased risks of various cancers and diseases.
Depo Provera Lawsuit claims are being filed by individuals who allege they developed meningioma (a type of brain tumor) after receiving Depo-Provera birth control injections.
A 2024 study found that women using Depo-Provera for at least 1 year are five times more likely to develop meningioma brain tumors compared to those not using the drug.
Suboxone Tooth Decay Lawsuit claims are being filed against Indivior, the manufacturer of Suboxone, a medication used to treat opioid addiction.
Claims allege that Indivior failed to adequately warn users about the potential dangers of severe tooth decay and dental injuries associated with Suboxone’s sublingual film version.
Social Media Harm Lawsuits are being filed against social media companies for allegedly causing mental health issues in children and teens.
Claims allege that companies like Meta, Google, ByteDance, and Snap designed addictive platforms that led to anxiety, depression, and other mental health issues without adequately warning users or parents.
Transvaginal Mesh Lawsuits are being filed against manufacturers of transvaginal mesh products used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Claims allege that companies like Ethicon, C.R. Bard, and Boston Scientific failed to adequately warn about potential dangers — including erosion, pain, and infection.
Bair Hugger Warming Blanket Lawsuits involve claims against 3M — alleging their surgical warming blankets caused severe infections and complications (particularly in hip and knee replacement surgeries).
Plaintiffs claim 3M failed to warn about potential risks — despite knowing about increased risk of deep joint infections since 2011.
Baby Formula NEC Lawsuit claims are being filed against manufacturers of cow’s milk-based baby formula products.
Claims allege that companies like Abbott Laboratories (Similac) and Mead Johnson & Company (Enfamil) failed to warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants.
Here, at TruLaw, we’re committed to helping victims get the justice they deserve.
Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?